Patents by Inventor G. Andrew Franz

G. Andrew Franz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of administering levothyroxine pharmaceutical compositions
    Patent number: 7101569
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Grant
    Filed: August 14, 2002
    Date of Patent: September 5, 2006
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
    Patent number: 7067148
    Abstract: A pharmaceutical composition with ?-sheet microcrystalline cellulose with improved potency life and methods of preparation therefor. Improved thyroid hormone pharmaceutical compositions comprising 50 weight % or more of ?-sheet microcrystalline cellulose.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: June 27, 2006
    Assignee: King Pharmaceutical Research & Development, Inc.
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20040043066
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: March 4, 2004
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions and methods
    Publication number: 20030224047
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: April 28, 2003
    Publication date: December 4, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique Tmax properties
    Publication number: 20030203967
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 30, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions and methods
    Publication number: 20030203968
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: April 28, 2003
    Publication date: October 30, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Levothyroxine pharmaceutical compositions, methods of making and methods of administration
    Publication number: 20030198668
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 15, 2002
    Publication date: October 23, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions and methods
    Publication number: 20030199588
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: April 28, 2003
    Publication date: October 23, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique plasma AUC properties
    Publication number: 20030198671
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 10, 2002
    Publication date: October 23, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Unique levothyroxine aqueous materials
    Publication number: 20030199586
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 23, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions and methods
    Publication number: 20030199585
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 10, 2002
    Publication date: October 23, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triidothyronine plasma AUC properties
    Publication number: 20030198672
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 23, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique Cmax properties
    Publication number: 20030199587
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 23, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Cmax properties
    Publication number: 20030194437
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 16, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Methods of administering levothyroxine pharmaceutical compositions
    Publication number: 20030194422
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 16, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030195254
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 16, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
    Publication number: 20030195253
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form, wherein the levothyroxine is unadsorbed. also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 16, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030190350
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: October 9, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Methods of stabilizing pharmaceutical compositions
    Publication number: 20030190349
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 10, 2002
    Publication date: October 9, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030190359
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: October 9, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma